Datasheet | March 4, 2025

CellGenix® Preclinical Recombinant Human Interleukin-12 (rh IL-12)

Source: Sartorius
Sartorius CellGenix® Preclinical Recombinant Human Interleukin-12 (rh IL-12)

Interleukin-12 (IL-12) is a pivotal cytokine in the immune system, playing a significant role in regulating immune responses. It is essential for the differentiation of naive CD4+ T cells into Th1 cells, which are crucial for the body's defense against intracellular pathogens. In the realm of cell and gene therapy, IL-12 is utilized for the ex vivo activation and expansion of T-cells. This includes its application in chimeric antigen receptor T-cell (CAR-T) therapy, NK cell therapy, and T-cell receptor (TCR) therapy.

Access the full datasheet to learn more.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online